OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
53
Results
Show all
Save search
Copy query
Show results for
Unknown
(53)
Publication Date
Release Date
2025
(13)
2021
(8)
2023
(6)
2024
(5)
2022
(5)
2020
(5)
2017
(3)
2014
(3)
2018
(2)
2026
(1)
2012
(1)
2010
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Nusinersen Modulates Proteomics Profiles of Cerebrospinal Fluid in Spinal Muscular Atrophy Type 1 Patients.
Not available
S-EPMC8122268
|
biostudies-literature
Cite
Prader-willi syndrome: clinical aspects.
Not available
S-EPMC3486015
|
biostudies-literature
Cite
Juvenile Idiopathic Arthritis, Uveitis and Multiple Sclerosis: Description of Two Patients and Literature Review.
Not available
S-EPMC9405697
|
biostudies-literature
Cite
Early Access to Oral Antivirals in High-Risk Outpatients: Good Weapons to Fight COVID-19.
Not available
S-EPMC9695104
|
biostudies-literature
Cite
A unique four-hub protein cluster associates to glioblastoma progression.
Not available
S-EPMC4106866
|
biostudies-literature
Cite
Synthesis of α-Hydroxy Fatty Acids from Fatty Acids by Intermediate α-Chlorination with TCCA under Solvent-Free Conditions: A Way to Valorization of Waste Fat Biomasses.
Not available
S-EPMC8637944
|
biostudies-literature
Cite
Enhancing Visual Exploration through Augmented Gaze: High Acceptance of Immersive Virtual Biking by Oldest Olds.
Not available
S-EPMC9914324
|
biostudies-literature
Cite
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
Not available
S-EPMC4005629
|
biostudies-literature
Cite
Telehealth vs in-person education for enhancing self-care of ostomy patients (Self-Stoma): Protocol for a noninferiority, randomized, open-label, controlled trial.
Not available
S-EPMC11206953
|
biostudies-literature
Cite
Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Not available
S-EPMC2909229
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets